Salvianolic acid membrane controlled release droppinig pills
A technology of salvianolic acid film and drop-release pills, which can be applied to medical preparations of non-active ingredients, cardiovascular system diseases, organic active ingredients, etc., and can solve the problems of unstable process reproducibility, technical difficulties in design and preparation, etc. problems, to achieve the effects of prolonging the effective time of action, good clinical compliance and treatment quality, and good treatment quality
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0055] 1 Instruments and materials
[0056] 1.1 Instruments and equipment
[0057] UV--1700 type ultraviolet-visible spectrophotometer (Shimadzu Co., Ltd.)
[0058] ZRS-8G Intelligent Drug Dissolution Apparatus (Tianda Tianfa Technology Co., Ltd.)
[0059] BY 40U Sugar Coating Machine (Taizhou Jintai Pharmaceutical Machinery Co., Ltd.)
[0060] 1.2 Materials
[0061] Polyethylene glycol 400 (PEG400) (analytical grade, Tianjin Damao Chemical Reagent Factory, Tianjin, China)
[0062] Polyethylene glycol 6000 (PEG6000) (analytical grade, Tianjin Damao Chemical Reagent Factory, Tianjin, China)
[0063] Diethyl phthalate (DEP) (analytical grade, Tianjin Damao Chemical Reagent Factory, Tianjin, China) ethyl cellulose (Shanghai Colorcon Coating Technology Co., Ltd., Shanghai, China)
[0064] Low permeability acrylic resin Eudragit (RS 100) (Degussa China co.Ltd)
[0065] Hyperosmolar acrylic resin Eudragit (RL 100) (Degussa China co.Ltd)
[0066] 95% ethanol (analytical grade, T...
Embodiment 2
[0103] Ball core is with reference to prior art scheme, according to the method of embodiment uniform design optimal coating solution prescription:
[0104] Ethylcellulose 3.0g
[0105] Acrylic resin (RL100:RS100=1:1) 1.0g
[0106] Diethyl phthalate 2.5ml
[0107] 95% ethanol 100ml
[0108] Coating weight gain 3.0%
[0109] Three batches of salvianolic acid film sustained-release dropping pills were prepared according to the optimized prescription, and the 12-hour cumulative drug release was determined by UV spectrophotometry and high performance liquid chromatography. The results are shown in the appendix image 3 And attached Figure 4 , with image 3 And attached Figure 4 Curve 1 is the experimental result of batch 1, curve 2 is the experimental result of batch 2, and curve 3 is the experimental result of batch 3. image 3 And attached Figure 4 It can be seen that the drug release of the three batches of dripping pills is uniform and reproducible, and the results ...
Embodiment 3
[0114] The preparation method of embodiment 3 is identical to embodiment 1.
[0115] Ball core:
[0116] Salvianolic acid API 2.5g
[0117] PEG6000 15.0g
[0118] PEG400 2mL
[0119] Coating:
[0120] Ethylcellulose 3.0g
[0121] Acrylic resin (RL100:RS100=1.5:1) 1.0g
[0122] Diethyl phthalate 2.5ml
[0123] 95% ethanol 100ml
[0124]Coating weight gain 2.0%
PUM
| Property | Measurement | Unit |
|---|---|---|
| recovery rate | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 